The growth-promoting effect of Id-1 (inhibitor of differentiation/DNA binding) has been demonstrated in a number of human cancers. However, the mechanisms responsible for its action are not clear. In this study, we report that in prostate cancer cells, Id-1 promotes cell survival through activation of nuclear factor-jB (NF-jB) signalling pathway. After stable expression of Id-1 protein in LNCaP cells, we found that the Id-1 transfectants showed increased resistance to apoptosis induced by TNFa through inactivation of Bax and caspase 3. In addition, in the LNCaP cells expressing ectopic Id-1 protein, we also observed increased NF-jB transactivation activity and nuclear translocation of the p65 and p50 proteins, which was accompanied by upregulation of their downstream effectors Bcl-xL and ICAM-1. These results indicate that the Id-1-induced antiapoptotic effect may be via NF-jB signalling transduction pathway in these cells. In addition, inactivation of Id-1 by its antisense oligonucleotide and retroviral construct in DU145 cells resulted in the decrease of nuclear level of p65 and p50 proteins, which was associated with increased sensitivity to TNFa-induced apoptosis. Our results strongly suggest that Id-1 may be one of the upstream regulators of NF-jB and activation of NF-jB signalling pathway may be essential for Id-1 induced cell proliferation through protection against apoptosis. Our findings also suggest a potential therapeutic strategy in which inactivation of Id-1 may lead to sensitization of prostate cancer cells to chemotherapeutic drug-induced apoptosis.
Introduction
Id-1 (inhibitor of differentiation or DNA binding) is a member of the helix-loop-helix (HLH) transcription factor family that lacks a basic domain. It acts as a dominant inhibitor of the basic HLH transcription factors by forming heterodimers (Benezra et al., 1990) . Recently, increased Id-1 expression has been associated with cell proliferation, immortalization, invasion and aggressive malignant phenotype in several human cell lines (Hara et al., 1994 (Hara et al., , 1996 Alani et al., 1999; Lyden et al., 1999; Lin et al., 2000) . Therefore, it has been suggested as an oncogene in several studies. Most importantly, expression of Id-1 has been found in many types of human cancers and its expression level has been indicated as a marker for malignant progression in a number of human cancers including the prostate (Desprez et al., 1998; Kleeff et al., 1998; Maruyama et al., 1999; Kebebew et al., 2000; Langlands et al., 2000; Polsky et al., 2001; Schindl et al., 2001; Takai et al., 2001; Wilson et al., 2001; Ouyang et al., 2002a) . In a hormone-induced prostate cancer Noble rat model, we have found that Id-1 expression is increased with prostate cancer development from hyperplasia, dysplasia to malignancy (Ouyang et al., 2001) . In human prostate cancer, increased Id-1 expression is associated with Gleason grade and tumour progression (Ouyang et al., 2002a) . These lines of evidence indicate that Id-1 may play an essential role in prostate carcinogenesis and malignant progression. Although mechanisms responsible for Id-1-mediated tumorigenesis are not clear, recently, we and others reported an association between inactivation of RB/p16
INK4a pathway and Id-1-induced cell proliferation in mammalian cells Ohtani et al., 2001; Ouyang et al., 2002b) .
Nuclear factor-kB (NF-kB) family of transcription factors is activated by a wide range of stimuli, including growth factors, cytokines and oncogenic transformation (Baeuerle and Baltimore, 1996; Kim et al., 2002a) . In resting cells, NF-kB is maintained in an inactive state in the cytoplasm bound to the inhibitor IkB. Upon stimulation, IkB is degraded which activates NF-kB to translocate to the nucleus and bind to target genes (Verma et al., 1995; Baldwin Jr, 1996) . In addition, the transcription activity of NF-kB is also regulated in response to oncogenic stimulations such as serine/threonine kinase Akt and protein kinase A (Zhong et al., 1998; Madrid et al., 2000) . Few studies have also demonstrated that there is a cross-competition between NF-kB and p53, a major proapoptotic protein (Pise-Masison et al., 2000; Shao et al., 2000) . Activation of NF-kB has been shown to induce expression of antiapoptotic proteins such as Bcl-xL, which suppresses apoptosis through regulation of caspase activity therefore protecting cells from undergoing apoptosis (Wang et al., 1998; Wu et al., 1998) . Growing evidence supports the role of NF-kB in promoting survival and protecting against apoptosis in mammalian cells (Chen et al., 2001) . Recent studies have demonstrated that NF-kB signalling pathway is activated in a number of human cancers including prostate cancer; therefore, NF-kB activation has been proposed to be a mechanism of tumorigenesis in certain type of cancers (Palayoor et al., 1999; Chen et al., 2001; Li and Stark, 2002) . In prostate cancer, constitutive NF-kB activation is found in androgen-independent prostate cancer cell lines such as PC3 and DU145, which are highly resistant to TNFa-induced apoptosis, while the levels of activated NF-kB is low in androgen-dependent LNCaP cells, which is correlated with sensitivity to TNFa (Palayoor et al., 1999; Huang et al., 2001; Dhanalakshmi et al., 2002) . Therefore, it has been suggested that activation of NF-kB may be associated with prostate cancer progression from androgen dependence to androgen independence. However, little is known about mechanisms responsible for NF-kB activation in prostate cancer cells.
Since both NF-kB activation and Id-1 expression are frequent events in prostate cancer and their expression is associated with prostate cancer progression (Palayoor et al., 1999; Huang et al., 2001; Ouyang et al., 2001; Dhanalakshmi et al., 2002; Ouyang et al., 2002a) , in this study, we investigated if there was any interaction between Id-1 and NF-kB signalling pathway in prostate cancer cells. It has been reported that in LNCaP cells, NF-kB signalling pathway is inactive (Palayoor et al., 1999; Gupta et al., 2002) . Previously, we have introduced ectopic Id-1 expression in these cells, which showed undetectable levels of Id-1 in serum-free culture conditions, and generated several stable transfectant clones expressing different levels of Id-1 protein . Using these transfectants, in this study, we investigated the effect of ectopic Id-1 expression on NF-kB signalling pathway and its role in promoting cell survival. In addition, we studied the effect of Id-1 inactivation on NF-kB signalling using an antisense Id-1 oligonucleotide and a retroviral construct in DU145 cells, which showed high levels of Id-1 (shown in the present study) and constitutive activation of NF-kB (Palayoor et al., 1999; Huang et al., 2001; Dhanalakshmi et al., 2002) . Our results indicate that the growth-promoting effect of Id-1 is regulated through activation of NF-kB, leading to protection against apoptosis in prostate cancer cells and Id-1 may be an upstream regulator of the NF-kB signalling pathway.
Materials and Methods

Cell culture
Human prostate adenocarcinoma cell lines, LNCaP and DU145, were obtained from American Type Culture Collection (Rockville, MD, USA). The establishment of the LNCaP-Id-1 transfectants as well as LNCaP-pBabe was described previously and all the cell lines were maintained in RPMI 1640 (Sigma, St Louis, MO, USA) supplemented with 5% fetal calf serum (FCS) (Invitrogen, Carlsbad, CA, USA) at 371C in 5% CO 2 . For the TNFa studies, the medium was changed to FCS-free RPMI 1640 serum-free medium (SFM) for 48 h before adding TNFa.
Extraction of nuclear fraction
Cells (5 Â 10 6 ) were collected by trypsinization, washed with PBS and then resuspended in Buffer A (10 mm HEPES pH 7.6, 60 mm KCl, 1 mm EDTA, 0.075% NP-40, 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mm PMSF). After incubation on ice for 3 min, the cell nuclear pellet was collected by centrifugation at 1500 g for 4 min at 41C. The supernatant containing the cytosolic fraction was discarded and the pellet was washed with 1 ml of Buffer B (10 mm HEPES pH 7.6, 60 mm KCl, 1 mm EDTA, 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mm PMSF) and then centrifuged again. The pellet was resuspended in 100 ml of Buffer C (20 mm Tris/HCl pH 8.0, 420 mm NaCl, 1.5 mm MgCl 2 , 0.2 mm EDTA, 25% glycerol 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mm PMSF) and then incubated on ice for 10 min. After centrifugation at 14 000 g for 10 min at 41C, the supernatant was collected as nuclear fraction and then assayed for protein concentration by Bio-rad protein assay (Bio-Rad, Hercules, CA, USA) before used for Western blotting analysis.
Western blotting
Detailed experimental procedures were described previously . Briefly, whole-cell lysate was prepared by resuspending cell pellet in lysis buffer (20 mm Tris-HCl (pH 7.4), 150 mm NaCl, 1 mm EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mm sodium pyrophosphate, 1 mm b-glycerophosphate, 1 mm Na 3 VO 4 , 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mm PMSF). Protein concentration was determined using D C Protein Assay kit (Bio-Rad, Hercules, CA, USA). Protein suspension from the whole-cell lysate (30 mg) or nuclear fraction (20 mg) was loaded onto a SDS-polyacrylamide gel for electrophoresis and then transferred to a PVDF membrane (Amersham, Piscataway, NJ, USA). The membrane was then incubated with primary antibody for 1 h at room temperature against Id-1, Bcl-x L , ICAM-1, IkB-a, Bax, caspase-3, b-actin, NF-kB/p50, NF-kB/p65, Histone H1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), PARP and cleaved PARP (Cell signaling Technology, Beverly, MA, USA), respectively. After washing with TBS-T, the membrane was incubated with secondary antibody against mouse or rabbit IgG and the signals were visualized using ECL plus Western blotting system (Amersham, Piscataway, NJ, USA).
Cell cycle analysis
Cells (5 Â 10 5 ) were plated in 5% FCS culture medium. After 24 h, the culture medium was replaced by SFM with or without the addition of TNFa for 48 or 72 h. The cells were harvested by trypsinization and then fixed in ice-cold 70% ethanol as described previously .
Luciferase assay
Cells were plated into a 12-well plate at a density of 1 Â 10 5 cells per well. After 24 h, the medium was changed to SFM and the cells were then cotransfected with a plasmid containing the NF-kB-luciferase reporter (a gift from Dr T Gilmore, Boston University, MA, USA) (Baldwin Jr et al., 1991) and pRL-TK-Luc vector, an internal control for transfection efficiency, using Fugene 6 (Roche, Berkeley, CA, USA) according to the manufacturer's procedure. At 48 h after transfection, the cells were lysed for luciferase assay using the Dual-luciferase reporter assay system (Promega, WI, USA).
Detection of apoptotic cells by 4
0 ,6-diamidino-2-phenylindole staining Cells were plated onto 12 mm cover glass and the medium was changed to SFM at approximately 30% confluence for 48 h. The cells were then treated with TNFa for either 48 or 72 h. They were fixed in ice-cold acetone and methanol (1 : 1), washed with PBS, and then stained with 4 0 ,6-diamindino-2-phenylindole (DAPI) for 5 min. The stained cells were examined under a fluorescent microscope and cells were considered to undergo apoptosis based on the appearance of nuclear fragmentation. A total of 500 cells were counted in five fields per sample. The percentage of apoptotic cells was calculated as the number of apoptotic cells over the total number of cells counted Â 100.
Antisense oligonucleotide treatment of DU145 cells
Phosphorothiolated oligonucleotide of the antisense Id-1 gene and the control oligomer were synthesized (Invitrogen, Carlsbad, CA, USA) and dissolved in TE (10 mm TrisCl pH 7.4,. 1 mm EDTA pH 8.0) as previously described (Barone et al., 1994; Hara et al., 1994; Desprez et al., 1995) . The cells were first cultured in SFM for 48 h and the oligonucleotide (10 or 20 mm) was added.
Generation of Id-1 antisense transfectants
Human full-length Id-1 cDNA was amplified from pcDNAId1 (a gift from Dr E Hara, Paterson Institute for Cancer Research, Manchester, UK) (Hara et al., 1996) by PCR (35 cycles (at 941C for 30 min, 531C for 30 min and 721C for 30 min)) with forward (5 0 -GAATTCGCGACACAAGATGC-3 0 ) and reverse primer (5 0 -AAGTCGACATGAAAGTCGC-CAG-3 0 ). The PCR product was cloned into the retrovirus vector (pBabePuro) in antisense orientation and the resulting construct was transfected into the retroviral packaging cell line PG13. At 48 h after the transfection, the supernatant containing viral particles was collected and used to infect the DU145 cells as described previously . Stable transfectants were selected in puromycin (2 mg/ml) and two of the transfectant clones were generated for further analysis.
Results
Id-1 expression protects LNCaP cells from TNFa-induced apoptosis
Previously, we found that expression of Id-1 was undetectable in serum-free culture conditions in LNCaP cells and generated stable transfectants expressing different levels of Id-1 in the absence of serum . In this study, we investigated if ectopic Id-1 expression was able to protect LNCaP cells from apoptosis induced by TNFa. As shown in Figure 1a , seven Id-1 transfectant clones showed different levels of Id-1 expression in the cells cultured in SFM, while in the vector control (pBabe) and the parental cells LNCaP, Id-1 was undetectable. Three Id-1 transfectants (C1, C2, C3) and controls were cultured in SFM for 48 h before adding TNFa and the percentage of apoptotic cells (percentage of cells showing nuclear fragmentation) was studied. As shown in Figure 1b , after exposure to TNFa for 48 and 72 h, percentage of apoptotic cells was found to be high in the controls (up to 60%), but it was much lower in the Id-1 transfectants (up to 17%). Flow cytometric studies also showed that percentage of sub-G1 cells was much higher (up to 67.5%) in the controls pBabe and LNCaP compared to the Id-1 transfectants (up to 13.4%, Figure 1c) . The percentage of TNFainduced apoptotic and sub-G1 cells was dependent on exposure time (Figure 1b and c) and TNFa concentration (data not shown). These results indicate that exogenous expression of Id-1 was able to protect LNCaP cells from TNFa-induced apoptosis. However, we also noticed that the percentage of apoptosis and sub-G1 cells was not correlated with Id-1 expression levels in these transfectant clones. Since our experiments were designed to study the relatively short-term effect of TNFa exposure (up to 72 h), it is possible that longer time points may be able to reveal a more significant correlation. We are currently investigating the effect of Id-1 expression on colony-forming ability of LNCaP cells in response to TNFa treatment, which measures survival of individual cells.
To further confirm the results from the apoptosis studies, we investigated the effect of TNFa on the expression of p53, Bax, caspase 3 and PARP, which have been shown to mediate TNFa-induced apoptosis in prostate cancer (Gurumurthy et al., 2001; Gupta et al., 2002) . Since LNCaP harbours a functional p53 gene, we found that p53 protein expression was increased with increased TNFa concentrations (5 and 10 ng/ml) in all of the cell lines regardless of Id-1 levels (up to threefold, Figure 2a ). Bax has been shown to be a downstream effector of the p53 protein in response to TNFa (Raffo et al., 2000) . As shown in Figure 2b , after exposure to TNFa, Bax levels were greatly increased (4 -6-fold) in the controls, but the increment was much lower in the Id-1 transfectants (1.1-3.2-fold). Caspase 3 is one of the critical enzymes of apoptosis, it is present normally in a cell as an inactive form with molecular weight of 32 kDa (procaspase). Once activated, it is cleaved into two subunits with molecular weights of 17 and 12 kDa (Stennicke and Salvesen, 1997). As shown in Figure 3c , in LNCaP and pBabe cells, the levels of the 32 kDa procaspase 3 protein (upper band) were reduced after TNFa treatment but the active form of this protein, a 17 kDa fragment (lower band), was increased compared to the untreated cells. In contrast, in the Id-1 transfectants, the procaspase 3 protein was consistently present even after TNFa treatment and there was no (C1 and C2) or barely detectable levels (C3, 10 ng/ml TNFa) of the fragmented caspase 3 protein in these cells. These results indicate that TNFa treatment led to activation of caspase 3 in the cells with undetectable levels of Id-1 but not the Id-1-expressing cells.
In cells that have become committed to undergo apoptosis, the 116 kDa polypolymerase (PARP) protein is cleaved by the activated caspase 3, producing 85 and Id-1 activates NF-jB signalling pathway M-T Ling et al 25 kDa fragments leading to biochemical and morphological changes associated with apoptosis (Kaufmann et al., 1993) . Therefore, we next studied the expression of PARP in the Id-1 transfectants and the controls (Figure 2d ). We found that the 116 kDa, but not the 85 kDa, PARP protein was present in all of the cell lines regardless of Id-1 levels. After exposure to TNFa, the PARP protein was undetectable or barely detectable in the controls, but the cleavaged PARP fragment of 85 kDa was increased. In the Id-1 transfectants, there was also evidence of the cleaved PARP; however, the levels of this 85 kDa protein were much lower than in the controls. In addition, the 116 kDa protein was also present even after TNFa treatment, indicating that the cleavage of PARP in Id-1 transfectants was not complete as observed in the controls (Figure 2d ). It is possible that the relatively low levels of activated caspase 3 in the Id-1 transfectants were not sufficient to induce complete cleavage of the PARP protein. These results also agree with the apoptosis experiments (Figure 1 ) that reduced apoptosis rate was observed in the Id-1 transfectants compared to the controls. Results so far implicate that ectopic Id-1 expression protected LNCaP cells from TNFa-induced apoptosis through suppression of Bax expression and activation of caspase 3.
Expression of Id-1 activates NF-kB signalling pathway in LNCaP cells
It was reported that NF-kB pathway was inactive in LNCaP cells (Palayoor et al., 1999) . In the present study, we investigated if activation of NF-kB signalling pathway in the Id-1 transfectants was responsible for the protection of Id-1 to TNFa-induced apoptosis in LNCaP cells. Since NF-kB translocates from cytoplasm to the nucleus upon activation (Verma et al., 1995; Baldwin Jr, 1996) , we studied the expression of the two most abundant forms of NF-kB, p65 and p50, in the cell nuclear extract by Western blotting analysis. As shown in Figure 3a , increased NF-kB/p65 and NF-kB/p50 protein expression was found in the five Id-1-positive transfectants compared to the controls (up to fivefold increase). In addition, the transcription activity of the NF-kB responsive promoter was also greatly increased in the Id-1 transfectants (up to 25-fold, solid columns, Figure 3b ) compared to the controls (LNCaP and pBabe). These results indicate that expression of exogenous Id-1 protein has led to NF-kB activation in LNCaP cells. To further confirm these results, the expression of two of the immediate downstream effectors of NF-kB, BclxL and ICAM-1 (intercellular adhesion molecule) (Sevilla et al., 2001; Li and Stark, 2002) , was also studied. As shown in Figure 3c , protein levels of the BclxL were much higher in the Id-1 transfectants compared to the controls (up to sixfold), while ICAM-1 was undetectable in the controls but present in Id-1 transfectants. In addition, since the activation of NFkB is found to parallel and depend on degradation of IkBs (DiDonato et al., 1996) , we next studied the expression of one of the three major mammalian IkBs, IkB-a. We found decreased IkB-a in all of the Id-1 transfectants compared to the controls (up to 70% decrease) (Figure 3c ). These results clearly show that expression of exogenous Id-1 protein in LNCaP cells led to activation of NF-kB signaling transduction pathway.
Inhibition of Id-1 expression by antisense Id-1 leads to increased sensitivity to TNFa-induced apoptosis in DU145 cells
Unlike LNCaP cells, in DU145 cells, NF-kB is constitutively activated (Palayoor et al., 1999) . We also found that Id-1 levels were high in this cell line when cultured in SFM compared to LNCaP cells (Figure 4a ). To further confirm the association between Id-1 and NF-kB signalling pathway, we treated DU145 cells with an antisense Id-1 oligonucleotide to block the transcription of Id-1 and then studied its effect on NF-kB pathway. As shown in Figure 4b , after treatment with antisense Id-1 (10 and 20 mm) for 24 h, decreased Id-1 expression was observed (up to 70% reduction) in a dose-dependent manner, suggesting that antisense Id-1 treatment sufficiently inhibited Id-1 protein expression in DU145 cells. The expression levels of the nuclear NFkB and its downstream effectors, Bcl-xL and ICAM-1, were also reduced with decreased Id-1 expression (up to 50% reduction) (Figure 4b ). The reduction of Id-1, BclxL and ICAM1 expression as well as NF-kB nuclear translocation was dependent on the concentration of antisense Id-1 oligonucleotide. These results indicate that suppression of Id-1 expression not only reduced nuclear expression of NF-kB but also suppressed its signalling transduction.
We then studied whether Id-1 suppression could reduce the protective effect of NF-kB on TNFa-induced apoptosis in these cells. After cultured in SFM for 48 h, DU145 cells were treated with both antisense Id-1 and TNFa for 48 and 72 h and the percentage of apoptotic and sub-G1 cells was studied, and then compared with the cells cultured without Id-1 antisense oligonucleotide. As shown in Figure 4c and d, small percentage of DU145 cells underwent apoptosis (up to 10%) at 72 h after exposure to TNFa alone, while there was little evidence of apoptosis in the untreated cells or the cells treated with antisense Id-1 alone. These results also agree with previous reports that DU145 cells were Expression of histone was determined as a loading control. Note that increased p65 and p50 protein expression is shown in all five Id-1-positive transfectants (i.e. C1-3, C5, C6). (b) NF-kB transactivation activity in the controls and the Id-1 transfectants. NF-kBresponsive reporter plasmid was cotransfected with pRL-TK-Luc reporter, and the firefly and Renilla luciferase activities were quantified using the dual-luciferase reporter assay system. A plasmid PGL3-Luc without the NF-kB-responsive promoter was used as a negative control. Luciferase activity in each sample was compared with LNCaP cells, assigned the value of 1. Note that NFkB transactivation activity is increased in all five Id-1-positive transfectants (i.e. C1-3, C5, C6). Error bars indicate standard error of the means. (c) Expression of Bcl-xL, ICAM1 and IkB-a in whole-cell lysate by Western blotting analysis. Results represent three independent experiments. Quantitation of specific bands from Western blotting analysis was conducted by densitometric analysis and is shown as fold change at the bottom of each band as compared to LNCaP cells. Note that increased Bcl-xL and ICAM-1 levels are shown in all Id-1-positive transfectants. Concurrent to this, there is a corresponding decrease in IkB-a expression in all Id-1-positive transfectants compared with the controls Id-1 activates NF-jB signalling pathway M-T Ling et al resistant to TNFa-induced apoptosis due to its constitutively activated NF-kB pathway (Dhanalakshmi et al., 2002) . In contrast, after treatment with both TNFa and Id-1 antisense oligonucleotide, the percentage of TNFainduced apoptotic cells (Figure 4c ) and sub-G1 phase ( Figure 4d ) were sharply increased (up to 35.6%). In addition, both fragmented caspase and PARP levels were increased in response to addition of the antisense Id-1 oligonucleotide (Figure 4e ). These results suggest that downregulation of Id-1 by its antisense oligonucleotide results in inactivation of NF-kB signalling pathway and increased sensitivity to TNFa-induced apoptosis in DU145 cells.
To further confirm the above findings, we introduced an antisense Id-1 construct into DU145 cells and generated stable transfectant clones. As shown in Figure 5a , two clones were isolated with approximately 60-80% reduction of Id-1 protein expression compared to the parental line and the pBabe vector control cells. In addition, downregulation of the active forms of NFkB proteins, p65 and p50, ICAM-1 and Bcl-x L was also observed (Figure 5b ). Subsequent apoptosis, flow cytometry and Western blotting experiments further confirmed the results observed in DU145 cells treated with antisense oligonucleotide (Figure 5c-e) . Studies on both antisense Id-1 oligonucleotide-treated DU145 cells and subsequent transfection experiments using antisense Id-1 construct clearly demonstrate that downregulation of Id-1 protein expression leads to inactivation of NFkB signalling pathway and increased sensitivity to TNFinduced apoptosis in DU145 cells.
Discussion
In this study, we report that ectopic expression of Id-1 protein resulted in the activation of NF-kB signalling pathway and protection of TNFa-induced apoptosis in prostate cancer cells. In addition, downregulation of Id-1 not only led to reduction of nuclear translocation of NF-kB, but also suppression of its signalling transduction and its protective role in TNFa-induced apoptosis in DU145 cells. Our results indicate that the growthpromoting effect of Id-1 in prostate cancer cells may be regulated through activation of NF-kB signalling pathway.
Although the role of Id-1 in tumorigenesis and malignant progression has been demonstrated (Hara et al., 1994 (Hara et al., , 1996 Alani et al., 1999; Lyden et al., 1999; Lin et al., 2000) , the mechanisms responsible for its action are not clear. Previously, it was reported that Id-1 was able to initiate DNA synthesis and induce cell cycle G1 to S transition in a number of cell lines (Hara et al., The results show that both fragmented caspase and PARP levels are high after Id-AS treatment. Note that Id-1AS treatment leads to downregulation of active forms of NF-kB proteins and sensitization to TNFa-induced apoptosis in DU145 cells
Id-1 activates NF-jB signalling pathway M- T Ling et al 1994 T Ling et al , 1996 . In addition, expression of Id-1 extended mammalian cell lifespan through transcriptional suppression of the p16 INK4a gene . In this study, we found that expression of Id-1 was able to protect prostate cancer cells from apoptosis through activation of NF-kB. The activated NF-kB pathway led to protection of TNFa-induced apoptosis by downregulation of Bax and cleavaged caspase 3 and Figure 5 Effect of antisense Id-1 retroviral construct (pBabe-Id-1AS) on NF-kB signalling pathway and TNFa-induced apoptosis in DU145 cells. Human full-length Id-1 cDNA was cloned into the retrovirus vector (pBabe) in antisense orientation and the resulting construct was used to infect the DU145 cells as described previously . Two stable transfectant clones, pBabe-Id-1AS-C1 and C2, were isolated. (Figure 2 ). It was reported that NFkB is a competitor of p53 during apoptosis thus promoting cell survival (Pise-Masison et al., 2000; Shao et al., 2000) . In the present study, we found that after exposure to TNFa, although increased p53 was found in all of the cell lines regardless of Id-1 levels (Figure 2a) , Bax levels were much higher in the controls. Since Bax has been shown to be directly regulated by p53 during apoptosis (Gupta et al., 2002) , it is possible that the Id-1-induced NF-kB activation is able to block the p53-induced Bax expression in LNCaP cells as previously suggested (Pise-Masison et al., 2000; Shao et al., 2000) . Another possible explanation for NF-kB-induced antiapoptosis effect is the induction of Bcl-xL ( Figure 3c) . As an antiapoptosis factor, increased Bcl-xL is associated with reduced apoptosis rate. In this study, increased Bcl-xL was found in Id-1 transfectants (Figure 3c ), but after inhibition of Id-1 protein expression, the Bcl-x L levels were decreased significantly (Figures 4b and 5b ). Since one of the major functions of Id-1 is to promote cell proliferation, it is possible that this effect is greatly facilitated by the activation of NFkB pathway thus protecting cells from apoptosis.
Although so far the Id-1-induced cell proliferation has been demonstrated through inactivation of RB/p16 INK4a pathway Ohtani et al., 2001; Polsky et al., 2001; Ouyang et al., 2002b) , recently we and others also found an association between Id-1 and TGFb (Ling et al., 2002a) and Ras-Raf-MEK pathways (Ohtani et al., 2001; Ling et al., 2002b) . Furthermore, recently a possible connection between Id-1 and NF-kB was also suggested in mouse lymphocytes (Kim et al., 2002b) . Since Id-1 is a regulator of transcription, it may be responsible for regulation of gene expression involving multiple transduction pathways. Therefore, it is not surprising that Id-1 may regulate cell growth through transcriptional activation of multiple pathways. The evidence that Id-1 counters cellular senescence through transcriptional repression of p16
INK4a ) and protects apoptosis through activation of NF-kB (present study) also supports this hypothesis.
Previously, ectopic expression of Id-1 and other Id family members such as Id-2 and Id-3 was suggested as inducers of apoptosis (Florio et al., 1998; Norton and Atherton, 1998; Tanaka et al., 1998) . For example, ectopic expression of Id-1 led to apoptosis in cardiac myocytes, while Id-3 was shown to induce apoptosis in fibroblasts (Norton and Atherton, 1998; Tanaka et al., 1998) . It seems that majority of results on Id-1-induced apoptosis comes from cells of nonepithelial origin. Recently, a report showed that ectopic Id-1 expression in mammary epithelial cells resulted in stimulating of proliferation when cultured at subconfluence in a SFM, but the same cells underwent apoptosis when cultured at high density (Parrinello et al., 2001) . These lines of evidence indicate that the role of Id-1 in cell survival may depend on the origin of the cells as well as in vitro culture conditions. In the present study, although all the experiments were performed in serum-free conditions, the cell density was at 60-70% confluency, which resulted in optimal cell growth in LNCaP cells. Therefore, the protective effect of Id-1 was observed in response to TNF-induced apoptosis as reported previously (Parrinello et al., 2001) .
In this study, the fact that both Id-1 expression and constitutive NF-kB activation are found in the androgen-independent DU145 cells but not in the androgendependent LNCaP cells indicates that Id-1 may also play a role in the progression to androgen independence. Recently, it was found that Id-1 expression can be induced by oestrogen in breast cancer cells and it was suggested that Id-1 may be an upstream target for steroid hormone action (Lin et al., 2000) . In addition, Id-1 expression was increased during the development of sex-hormone-induced prostate cancer in a Noble rat model (Ouyang et al., 2001) , further implicating its role in mediating hormone response in cancer cells. It is possible that increased Id-1 expression during prostate cancer progression may provide survival advantage for cancer cells through activation of NF-kB signalling pathway, which may then facilitate progression from androgen-dependent to -independent growth. This hypothesis is supported by the evidence in the present study that when the Id-1 expression was reduced either by antisense oligonucleotides or a vector construct in DU145 cells, the nuclear levels of NF-kB and its downstream effectors, Bcl-xL and ICAM-1, were also decreased, which was accompanied by activation of caspase 3 and PARP and increased sensitivity to TNFa (Figures 4 and 5) . Recently, it was reported that blockage of NF-kB in PC3 cells resulted in suppression of invasion and metastasis ability (Huang et al., 2001) , and since one of the functions of Id-1 is to promote invasion and metastasis (Lyden et al., 1999; Lin et al., 2000) , these results support a link between Id-1 and NFkB pathway in prostate cancer. Our preliminary results also showed that the androgen-sensitive cell line LNCaP had undetectable levels of Id-1 protein but expressed Figure 6 Proposed model for Id-1 mediated NF-kB activation and apoptosis in human prostate cancer cells Id-1 activates NF-jB signalling pathway M-T Ling et al androgen receptor; however, the two androgen independent cell lines, PC3 and DU145, had relatively high levels of Id-1 protein but androgen receptor was undetectable. In addition, androgen receptor expression was observed when Id-1 expression was reduced in DU145 cells infected with antisense Id-1 construct (data not shown). These results indicate a reverse relation between Id-1 protein and androgen receptor and it is possible that Id-1 may be able to mediate androgen response through regulation of androgen receptor expression. We are currently studying the association between Id-1 expression and androgen response and invasion ability in prostate cancer cells. The major finding of this study is that the growthpromoting effect of Id-1 is through activation of NF-kB leading to protection of apoptosis in prostate cancer cells. The activated downstream effectors such as Bcl-xL may be able to counteract with apoptosis-promoting factors such as Bax therefore inhibiting caspase 3 activation and protecting cells from undergoing apoptosis as depicted in Figure 6 . Our findings also suggest a therapeutic strategy in which inactivation of Id-1 may lead to sensitization of prostate cancer cells to chemotherapeutic drug-induced apoptosis.
